-
design novel immunotherapies to prevent relapse in acute myeloid leukemia (AML), an aggressive and common form of hematological cancer. The most promising immunotherapeutic strategies will be tested in
Searches related to Design
Enter an email to receive alerts for Design "FNRS WELBIO" positions